Supporting these hypotheses, recently it has been shown that the suppression of IRS2/AKT signalling prevents hepatic steatosis, non-alcoholic fatty liver disease (NAFLD) and liver cancer57 indicating the importance of balance in the anabolic and catabolic response. This evidence concerns the gene AKT1 and Hepatic steatosis.